Using Vanrx Workcells, pharmaceutical companies can bring injectable medicines to market faster. Short changeover times and flexible systems enable high-value, small volume production.
Vanrx is introducing the Microcell Vial Filler, a new gloveless robotic isolator for aseptic filling. The Microcell is focused on clinical trial production and development of sterile injectable biopharmaceuticals, cell therapies and personalized medicines.Read More
“The companies that are adopting the Multiplex strategy are beating traditional supply chains in terms of cost of goods, time to market and quality,” says Chris Procyshyn, CEO of Vanrx. This is a must-read for executives looking to create a sustainable competitive advantage.”Read More
Our team members have developed and brought complex drug products to market. We know what you need now, and are designing for the future.
Get a detailed view of how Aseptic Filling Workcells compare to conventional technologies and help bring drug products to market faster.Download the white paper
Mar 6 - Mar 7, 2018
Reston, VA, USA
Mar 13 - Mar 13, 2018
Raleigh, NC, USA
Mar 19 - Mar 22, 2018
San Francisco, CA, USA